SIRIAMLAB

Method

Neuroanatomy as a design language.

The map comes first. The composition follows.

Dermatomal mapping

Each application field is defined by the surface territory associated with a spinal or cranial nerve segment.

Peripheral architecture

Plexus formations — brachial, lumbar, coeliac — guide how a family covers a broader projection field.

Neurocutaneous interface

Formulations are composed for the cutaneous surface, with texture and carrier chosen for the region.

Reproducible routines

Structured protocols make application consistent across time and across practitioners.

Method

From assessment to follow-up

A four-step framework used consistently across all product families.

  1. 01

    Assessment

    The application region is identified using anatomical landmarks, dermatome maps and professional judgement.

  2. 02

    Application

    The corresponding formulation is applied to the defined neurocutaneous surface zone.

  3. 03

    Protocol

    A structured routine defines frequency, quantity and duration for consistent, reproducible use.

  4. 04

    Follow-up

    Observations are documented over time and reviewed together with the healthcare professional.

Principles

What guides the work

Anatomical reference

Every family is defined against recognised segmental anatomy rather than against a symptom or a claim.

European development

Formulations are developed and produced in Europe under cutaneous topical quality standards, with composition disclosed.

Professional dialogue

Method and documentation are reviewed with physicians, therapists and applied practitioners.

Neutral information

Material is written to explain where and how a formulation is applied, without persuasion.

Continuous refinement

The method is versioned; each revision states what changed and what it replaces.

Method evolution

A method that is versioned

Each revision states what it changed and what it replaces. Superseded versions remain documented.

  1. Method 1.0SupersededRegion defined by anatomical landmark description alone.
  2. Method 2.0SupersededDermatomal and plexus indexing added; composition matched to region characteristics.
  3. Method 3.0CurrentMetameric indexing across 31 segments, six atlas layers and versioned protocol documentation.
  4. Method 4.0In preparationExtension towards viscerotomes, sclerotomes, myotomes and autonomic pathways.

Scope

SIRIAM LAB formulations are cutaneous topical products. The material presented here is educational and structural in nature. It does not constitute medical advice, and no therapeutic effect is claimed or implied.

What we document

Concepts, methodology, anatomical reference material and educational resources. Each page states what it is and what it is not.

What we do not claim

No therapeutic effect, no diagnosis, no clinical evidence. Internal observations are never presented as study results.

How material is revised

Documentation is versioned. Superseded material is marked as such rather than removed silently.

Where interpretation belongs

Clinical judgement remains with the treating healthcare professional. The institute supplies reference material only.

Knowledge graph

Related knowledge

The anatomical vocabulary behind the formulation architecture.